Japan Lifeline Co., Ltd. (TSE: 7575)
Health Care · Health Care Equipment & Supplies · JP
¥1,576.00
+3.01% today · +6.1% 1Y
Japan Lifeline Co., Ltd. (TSE: 7575) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $695.51M and employs 1,304 people.
Over the last twelve months the share price has gained 6.1%, trading between 1.24K and 1.65K.
Tweenvest scores Japan Lifeline Co., Ltd. across four factors: quality 85/100, value 35/100, growth 28/100, dividend 90/100. Its strongest factor is dividend.
7575 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $695.51M
- Revenue (TTM)
- $372.05M
- P/E
- 11.82
- EPS
- 133.35
- Dividend yield
- 3.55%
- Beta (5Y)
- 0.21
- 52-week high
- ¥1,645.00
- 52-week low
- ¥1,239.00
- Avg volume (3M)
- —
- Shares outstanding
- 70.16M
- Employees
- 1,304
- Next earnings
- —
About Japan Lifeline Co., Ltd.
Japan Lifeline Co., Ltd. is a medical technology firm based in Japan that specializes in cardiovascular healthcare devices. Its operations encompass research, manufacturing, global procurement, and sales of these specialized medical instruments within the country. The company's diverse product range includes solutions for cardiac rhythm management, such as pacemakers, implantable cardioverter defibrillators (including subcutaneous models), cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support tools. For electrophysiology and ablation procedures, Japan Lifeline offers various electrophysiological and ablation catheters (like irrigated tip versions), endoscopic balloon ablation systems, esophageal temperature monitors, internal atrial cardioversion systems, and radio-frequency transseptal needles. Furthermore, its portfolio extends to cardiovascular and endografting products, including vascular, open, and abdominal stent-grafts. In the transvascular intervention segment, the company provides PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and devices for closing atrial septal defects. Complementing these, its gastrointestinal intervention solutions encompass radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Established in 1981, Japan Lifeline Co., Ltd. maintains its headquarters in Tokyo, Japan.
- ISIN
- JP3754500001
- Founded
- 1981
- Listed since
- Jan 4, 2000
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.35 | +0.75% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.